Reports

The Department for Business and Trade (DBT) has produced the Genomics Spotlight 2024 to showcase the UK’s expertise in genomics and the latest developments that make the UK a hub for genomics business and investment.

Since the election in July, the BIA has been busy engaging with the new government. Read our latest influencing report to find out more.

The Synthetic & Engineering Biology British-Swiss Summit, held in May 2024 and formally opened by H.E. Markus Leitner, Ambassador of Switzerland to the United Kingdom, brought together over 25 representatives from academia, industry, and government bodies from the UK and Switzerland.

This report from the BIA illustrates the current policy context for R&D tax reliefs and argues for an evidence-based approach to tax policy.

Given the significant shortage of purpose-built labs, understanding the leasing process and having a knowledgeable team, is crucial. Read this guide to learn more and plan your lab acquisition effectively.

With the Prime Minister calling a snap election set for 4 July, the BIA’s attention has turned to preparing for the next government. Meanwhile, Parliament Day, our flagship day of parliamentary engagement, has been postponed to the autumn. Official engagements with civil servants have also been restricted in accordance with the pre-election period of sensitivity.

With a general election widely expected to be called later this year, the BIA’s long-established relationships with senior parliamentarians have been of particular importance this quarter. From launching the Labour Party’s Life Science Sector Strategy in Stevenage in January to hosting Science Minister Andrew Griffith MP at our Gala Dinner, we continue to represent the sector at the highest levels.

A Prescription for Growth is the Labour Party’s plan for the life sciences sector.

An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.